BIOMAT Database Logo BIOMAT Database Logo

Significance of Anti-C1q Antibodies in Patients with Systemic Lupus Erythematosus as A Marker of Disease Activity and Lupus Nephritis. 2016

Amal F Soliman, and Sami El-Said Egailla, and Eman R Abdel-Gawad, and Amira I Mansour, and Tohamy H ElKhouly, and Marwa Ya Mahgoub
Department of Rheumatology & Rehabilitation,Faculty of Medicine, Benha University, Benha, Egypt.

Anti-C1q autoantibodies have been proposed as a useful marker in SLE. This study aimed at measuring serum levels of anti-C1q antibodies in patients with SLE and investigates correlations of this level with the histopathological classes of renal biopsies and disease activity. The anti-C1q antibody level was measured in 30 females SLE patients and 20 controls. The activity of SLE disease was calculated according to the SLE disease activity index. A renal biopsy from patients with clinical manifestations of renal disease was obtained. There was a significant increase in the level of anti-C1q antibodies in SLE patients than controls and in patients with active LN than inactive LN (P<0.05). There were significant positive correlations between anti-C1q antibody level and SLEDAI & rSLEDAI scores and activity index score of renal biopsies. Anti-C1q antibodies showed higher diagnostic sensitivity and specificity than anti-dsDNA antibodies. In conclusion, anti-C1q antibodies are useful and sensitive non-invasive biomarker with high specificity in combination with anti-dsDNA antibodies for the diagnosis of renal disease activity.

UI MeSH Term Description Entries
D008181 Lupus Nephritis Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982). Glomerulonephritis, Lupus,Lupus Glomerulonephritis,Nephritis, Lupus,Glomerulonephritides, Lupus,Lupus Glomerulonephritides,Lupus Nephritides,Nephritides, Lupus
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015922 Complement C1q A subcomponent of complement C1, composed of six copies of three polypeptide chains (A, B, and C), each encoded by a separate gene (C1QA; C1QB; C1QC). This complex is arranged in nine subunits (six disulfide-linked dimers of A and B, and three disulfide-linked homodimers of C). C1q has binding sites for antibodies (the heavy chain of IMMUNOGLOBULIN G or IMMUNOGLOBULIN M). The interaction of C1q and immunoglobulin activates the two proenzymes COMPLEMENT C1R and COMPLEMENT C1S, thus initiating the cascade of COMPLEMENT ACTIVATION via the CLASSICAL COMPLEMENT PATHWAY. C1q Complement,Complement 1q,Complement Component 1q,C1q, Complement,Complement, C1q,Component 1q, Complement

Related Publications

Amal F Soliman, and Sami El-Said Egailla, and Eman R Abdel-Gawad, and Amira I Mansour, and Tohamy H ElKhouly, and Marwa Ya Mahgoub
Anti-C1q antibodies: association with nephritis and disease activity in systemic lupus erythematosus.
January 2009, Journal of clinical laboratory analysis,
Amal F Soliman, and Sami El-Said Egailla, and Eman R Abdel-Gawad, and Amira I Mansour, and Tohamy H ElKhouly, and Marwa Ya Mahgoub
Anti-C1q antibody as a marker of disease activity in systemic lupus erythematosus.
December 1999, The Indian journal of medical research,
Amal F Soliman, and Sami El-Said Egailla, and Eman R Abdel-Gawad, and Amira I Mansour, and Tohamy H ElKhouly, and Marwa Ya Mahgoub
Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China.
July 2011, Clinical rheumatology,
Amal F Soliman, and Sami El-Said Egailla, and Eman R Abdel-Gawad, and Amira I Mansour, and Tohamy H ElKhouly, and Marwa Ya Mahgoub
Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
June 2021, Immunity, inflammation and disease,
Amal F Soliman, and Sami El-Said Egailla, and Eman R Abdel-Gawad, and Amira I Mansour, and Tohamy H ElKhouly, and Marwa Ya Mahgoub
Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.
July 2009, International journal of rheumatic diseases,
Amal F Soliman, and Sami El-Said Egailla, and Eman R Abdel-Gawad, and Amira I Mansour, and Tohamy H ElKhouly, and Marwa Ya Mahgoub
Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
January 2014, Srpski arhiv za celokupno lekarstvo,
Amal F Soliman, and Sami El-Said Egailla, and Eman R Abdel-Gawad, and Amira I Mansour, and Tohamy H ElKhouly, and Marwa Ya Mahgoub
Anti-C1q antibodies in pregnant patients with systemic lupus erythematosus.
January 2007, Clinical and experimental rheumatology,
Amal F Soliman, and Sami El-Said Egailla, and Eman R Abdel-Gawad, and Amira I Mansour, and Tohamy H ElKhouly, and Marwa Ya Mahgoub
Anti-C1q antibodies in systemic lupus erythematosus.
January 2015, Lupus,
Amal F Soliman, and Sami El-Said Egailla, and Eman R Abdel-Gawad, and Amira I Mansour, and Tohamy H ElKhouly, and Marwa Ya Mahgoub
Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis.
January 2015, Disease markers,
Amal F Soliman, and Sami El-Said Egailla, and Eman R Abdel-Gawad, and Amira I Mansour, and Tohamy H ElKhouly, and Marwa Ya Mahgoub
Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus.
November 2003, Current opinion in nephrology and hypertension,
Copied contents to your clipboard!